Healthcare & Life Sciences
Valar Labs
United States
activeseries-b
series-b
Stage
2024
Founded
3
Investors
About
Valar Labs develops a computational histology platform that uses AI to analyze cancer tissue slides to predict tumor invasiveness and identify effective treatments, currently with a commercial test for bladder cancer and expanding to other cancers.
Explore Valar Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.